home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Rapid Exits

  April, 19 2005 10:13
your information resource in human molecular genetics
Immune cells traveling in the bloodstream can abruptly stop at signs of trouble according to new research in the May issue of Nature Immunology. By responding to chemical signals deposited on blood vessel walls, immune cells rapidly deploy specialized attachment molecules that latch onto cells lining the blood vessel, allowing their exit into the damaged tissues.

Previously, exit from the bloodstream was thought to be a gradual process that required braking before exiting at the site of final immune cell arrest. Ronen Alon and colleagues dispel this notion by showing immune cells can immediately stop upon encountering immobilized chemokines ? which act as traffic signals for these cells. Chemokines trigger extension of surface adhesion molecules called LFA-1. The process of extending these molecules unveils a specialized region that acts as a grappling hook for receptors expressed on blood vessel cells. Importantly, it is the immobilized form of chemokine that mediates this signal. The new work explains how immune cells that act as first responders can quickly arrive at scenes of damage.

Author contact:

Ronen Alon (Weizmann Institute of Science, Rehovot, Israel)
E-mail: ronen.alon@weizmann.ac.il

Also available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.